Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection

World Health Organization, 2012 Bartholomeusz, 2004, Hepatitis B virus genotypes: comparison of genotyping methods, Rev Med Virol, 14, 3, 10.1002/rmv.400 Miyakawa, 2003, Classifying hepatitis B virus genotypes, Intervirology, 46, 329, 10.1159/000074988 Chu, 2002, Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C, Gastroenterology, 122, 1756, 10.1053/gast.2002.33588 Wai, 2002, HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C, Hepatology, 36, 1425 Nebbia, 2012, Hepatitis B infection: current concepts and future challenges, Q J Med, 105, 109, 10.1093/qjmed/hcr270 Lok, 2007, Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management, Hepatology, 46, 254, 10.1002/hep.21698 Wang, 2009, Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues, Clin Ther, 31, 360, 10.1016/j.clinthera.2009.02.016 Lok, 2009, Chronic hepatitis B: update 2009, Hepatology, 50, 661, 10.1002/hep.23190 Tillmann, 2008, Telbivudine versus lamivudine in patients with chronic hepatitis B, N Engl J Med, 358, 1517, 10.1056/NEJMc080082 Yuen, 2009, Genetic variability of hepatitis B virus and response to antiviral treatments: searching for a bigger picture, J Hepatol, 50, 445, 10.1016/j.jhep.2008.12.005 Borroto-Esoda, 2007, Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials, J Hepatol, 47, 492, 10.1016/j.jhep.2007.06.011 Nie, 2012, Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion, J Hepatol, 56, 795, 10.1016/j.jhep.2011.11.012 Yuan, 2007, Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core ad their clinical implications, J Clin Virol, 39, 87, 10.1016/j.jcv.2007.03.005 Han, 2009, Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients, J Gastroenterol Hepatol, 24, 1417, 10.1111/j.1440-1746.2009.05864.x Zoulim, 2009, Hepatitis B virus resistance to nucleos(t)ide analogues, Gastroenterology, 137, 1593, 10.1053/j.gastro.2009.08.063 Wang, 2007, Hepatitis B virus genotypes and subgenotypes in China, Hepatol Res, 37, S36, 10.1111/j.1872-034X.2007.00102.x Zeng, 2005, Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China, J Viral Hepat, 12, 609, 10.1111/j.1365-2893.2005.00657.x Li, 2015, Investigation into drug-resistant mutations of HBV from 845 nucleoside analogue-naïve Chinese patients with chronic HBV infection, Antivir Ther, 20, 141, 10.3851/IMP2813 Song, 2012, Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleotide analogues, World J Gastroenterol, 18, 7149, 10.3748/wjg.v18.i48.7149